IL
Isomorphic Labs
United Kingdom · Biotech · Healthtech · AI · Enterprise software
Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $2.1B | Alphabet — Role not disclosedCapitalG — Role not disclosedGV (Google Ventures) — Role not disclosedMGX — Role not disclosedTemasek — Role not disclosedThrive Capital — Role not disclosedUK Sovereign AI fund — Role not disclosed |